Robert E. Hoffman
Board Member
FibroBiologics, Inc. (FBLG)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert E. Hoffman
Robert E. Hoffman is recorded as Board Member at FibroBiologics, Inc. (FBLG). FibroBiologics, Inc. reported in an 8-K filed May 5, 2025 that Robert E. Hoffman resigned as Interim Chief Financial Officer, effective May 14, 2025.
“On May 2, 2025, Mr. Robert E. Hoffman informed FibroBiologics, Inc. (the "Company") of his decision to voluntarily resign from his position as the Company's Interim Chief Financial Officer, effective as of the close of business on May 14, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2025-05-14
-
Start not stated–2025-05-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at FibroBiologics, Inc.
Other people whose current roles at this company are on record from its filings.
- Pete O’Heeron CEO, Board Member
- Jason D. Davis CFO
- Robert Hoffman CFO
- Ruben A. Garcia General Counsel
- Kathleen Rubins Board Member
- Kathleen Rubins, Ph.D. Board Member
- Leigh Steinberg Board Member
- Pete O'Heeron Board Member
- Richard Cilento Board Member
- Stacy Coen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.